The U.S. Congress greenlit a historic $315 million in federal ALS research funding for 2026 amid Rare Disease Month, spotlighting biotech progress like VectorY Therapeutics' first patient dosing in ...

EADaily, February 19th, 2026. Singer Lyubov Uspenskaya has not celebrated her birthday and other holidays for four years. She told Channel Five about this.

The first patient has been dosed in a Phase 1/2 clinical study of VTx-002, an experimental therapy for amyotrophic lateral sclerosis.

The study aims to enrol 12 adults with ALS at locations in Europe, the UK and US.

VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been dosed in its Phase 1/2 PIONEER-ALS trial evaluating ...

A male teenage pupil opened fire inside a secondary school in the latest school attack to shake Vladimir Putin's country. However, regional officials later confirmed that no one sustained ...

Russian singer Lyubov Uspenskaya has been recognized as a threat to the national security of Ukraine. The National Council for Television and Radio Broadcasting announced this, Ukrainian News Agency ...

Over the past year, BBC Eye has followed the journeys of young men from Syria, Egypt, and Yemen who travelled to Russia in search of work, only to end up on the frontlines in Ukraine. Why are these ...

Russia has previously spread rumours that paint Ukrainian leaders as 'Neo-Nazis' A MASKED schoolboy wearing a Hitler T-shirt allegedly stabbed a teacher and a 14-year-old classmate in a violent ...

Editor's note: Seymur Mammadov, a special commentator for News.Az, is the director of the international expert club EurAsiaAz. The article reflects the author’s personal opinion and does not ...

The killing of a 10-year-old schoolboy of Tajik origin in the Moscow region has prompted strong official reactions from both Russia and Tajikistan, while also resonating deeply among migrant ...